Atmaca, A. Et Al. 2022. No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study. OSTEOPOROSIS INTERNATIONAL , vol.33, no.1 , 273-282.

Atmaca, A., Demirci, I., Haymana, C., Tasci, I., Sahin, I., Cakal, E., ... Ata, N.(2022). No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study. OSTEOPOROSIS INTERNATIONAL , vol.33, no.1, 273-282.

Atmaca, A. Et Al. "No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study," OSTEOPOROSIS INTERNATIONAL , vol.33, no.1, 273-282, 2022

Atmaca, A. Et Al. "No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study." OSTEOPOROSIS INTERNATIONAL , vol.33, no.1, pp.273-282, 2022

Atmaca, A. Et Al. (2022) . "No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study." OSTEOPOROSIS INTERNATIONAL , vol.33, no.1, pp.273-282.

@article{article, author={A. Atmaca Et Al. }, title={No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study}, journal={OSTEOPOROSIS INTERNATIONAL}, year=2022, pages={273-282} }